Infoscience Epflmetadata only
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates
neurosciences, neurosciences & neurology, elezanumab, abt-555, acute spinal cord injury, thoracic, hemicompression, non-human primate
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 388254
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.